Literature DB >> 11998809

Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model.

Osamu Tasaki1, David W Mozingo, Michael A Dubick, Cleon W Goodwin, Loudon D Yantis, Basil A Pruitt.   

Abstract

OBJECTIVE: This study evaluates the effects of heparin alone and in combination with lisofylline, 1-(5-R-hydroxyhexyl)3,7-dimethylxanthine, on severe smoke injury.
DESIGN: Prospective animal study with concurrent controls.
SETTING: An animal laboratory.
SUBJECTS: Eighteen 1-yr-old female sheep, weighing 24-32 kg.
INTERVENTIONS: After smoke exposure and tracheostomy, animals were divided into three groups. Group S (n = 6) received nebulized saline through an endotracheal tube every 4 hrs for 48 hrs. Group H (n = 6) received 10,000 units of nebulized heparin every 4 hrs. Group LH (n = 6) was treated with nebulized heparin and intravenous infusion of lisofylline (10 mg x kg(-1) x hr(-1)) for 48 hrs after a bolus injection (20 mg/kg). Animals initially breathed room air spontaneously. If PaO2 was <50 torr and PaCO2 >60 torr, animals were mechanically ventilated. Sheep were killed 48 hrs postinjury.
MEASUREMENTS AND MAIN RESULTS: Blood gases were measured serially. At 48 hrs, ventilation perfusion distribution mismatching was analyzed by using the multiple inert gas elimination technique. Lung malondialdehyde was determined. The postinjury increase in alveolar-arterial oxygen tension gradient (LH, 36.7 +/- 3.5 vs. S, 89.0 +/- 24.6 torr at 48 hrs) was significantly attenuated in those animals receiving LH. The percentage of pulmonary shunt, Qs/Qt (LH, 20.8 +/- 4.9 vs. S, 36.6 +/- 4.6%), and the percentage of animals that required ventilation (LH, 0 vs. S, 67%) were significantly reduced in LH. Multiple inert gas elimination technique study showed that the true shunt fraction was decreased in LH. Lung malondialdehyde was significantly less in LH (LH, 0.33 +/- 0.06 vs. S, 0.56 +/- 0.09 nmol/mg protein). There was no significant difference in any of these variables between H and S.
CONCLUSION: Treatment with heparin alone did not attenuate pulmonary dysfunction after severe smoke injury. Combined treatment with nebulized heparin and systemic lisofylline had beneficial effects on pulmonary function in association with a decrease in blood flow to poorly ventilated areas and less lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11998809     DOI: 10.1097/00003246-200203000-00024

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Lung [(18)F]fluorodeoxyglucose uptake and ventilation-perfusion mismatch in the early stage of experimental acute smoke inhalation.

Authors:  Guido Musch; Tilo Winkler; R Scott Harris; Marcos F Vidal Melo; Tyler J Wellman; Nicolas de Prost; Richard L Kradin; Jose G Venegas
Journal:  Anesthesiology       Date:  2014-03       Impact factor: 7.892

Review 2.  Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.

Authors:  Andrew C Miller; Elamin M Elamin; Anthony F Suffredini
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

Review 3.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

4.  In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model.

Authors:  Florence Ader; Rozenn Le Berre; Rémi Fackeure; Dominique Raze; Franco Dante Menozzi; Nathalie Viget; Karine Faure; Eric Kipnis; Benoît Guery; Sophie Jarraud; Jerome Etienne; Christian Chidiac
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

Review 5.  Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.

Authors:  Jenny Juschten; Pieter R Tuinman; Nicole P Juffermans; Barry Dixon; Marcel Levi; Marcus J Schultz
Journal:  Ann Transl Med       Date:  2017-11

Review 6.  Inflammatory Mediators and Oxidative Stress in Animals Subjected to Smoke Inhalation: A Systematic Review.

Authors:  Fernanda Oliveira de Carvalho; Fernanda Araújo Felipe; Aida Carla Santana de Melo Costa; Luciana Garcez Barretto Teixeira; Érika Ramos Silva; Paula Santos Nunes; Saravanan Shanmugam; Waldecy de Lucca Junior; Jullyana S S Quintans; Adriano Antunes de Souza Araújo
Journal:  Lung       Date:  2016-04-25       Impact factor: 2.584

7.  Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury.

Authors:  Gilman B Allen; Mary E Cloutier; Yuna C Larrabee; Konstantin Tetenev; Stephen T Smiley; Jason H T Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-05       Impact factor: 5.464

Review 8.  Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations.

Authors:  Pieter R Tuinman; Barry Dixon; Marcel Levi; Nicole P Juffermans; Marcus J Schultz
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

9.  Pharmaco-management of inhalation injuries for burn survivors.

Authors:  Anthony C Bartley; Dale W Edgar; Fiona M Wood
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 10.  Inhalation injury: epidemiology, pathology, treatment strategies.

Authors:  David J Dries; Frederick W Endorf
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.